Tigeryeah Capital is a venture capital firm.
Business Model:
Revenue: $0
Employees: 0-0
Address: Dongguan Building, No. 618 Jiangnan Road
City: Hangzhou
State: zhejiang province
Zip: 310053
Country: CN
Founded in 2014, TigerYeah Capital team has in-depth experiences in investment management and professional healthcare background. TigerYeah is dedicated to build itself as a famous brand in healthcare investment field and become the top tier investment firm. Relying on their superior professional management team, TigerYeah will enable both clients and invested portfolio enterprises to gain the success. TigerYeah focuses on early and growing equity investment in healthcare, especially in the field of the Medical Device, Health Food, CRO and Health Services. By leveraging Tigermed solid platform and TigerYeah abundant industrial knowhow and resources, TigerYeah provides comprehensive post-investment services for entrepreneurs to accelerate the products&s; launch into market,speed up business development process, strengthen and upgrade the integration of the relevant industrial resources. TigerYeah is willing to contribute greater value as well as grow together with the enterprises.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2022 | Enze Kangtai | Series A | - |
5/2017 | Yaxincheng | Angel Round | 434.3k |
3/2021 | Novamab | Series A | 15.4M |
3/2017 | Hanyu Medical | Angel Round | - |
1/2021 | MagAssist | Series B | 0 |
12/2020 | Insight Lifetech | Series C | 27.6M |
12/2021 | Hesguard | Seed Round | 15.7M |
8/2022 | Epigenic Therapeutics | Seed Round | 0 |
3/2022 | Tingsheng Technology | Series A | 15.8M |
9/2017 | MED.CIRCLE | Angel Round | 450.8k |
4/2018 | Hanyu Medical | Venture Round | - |
4/2020 | Precogify | Seed Round | 2.8M |
5/2021 | Hangzhou DAC Biotech Co., Ltd | Series C | 154.9M |
8/2022 | Epigenic Therapeutics | Seed Round | 0 |
3/2022 | Tingsheng Technology | Series A | 0 |
1/2022 | Enze Kangtai | Series A | - |
12/2021 | Hesguard | Seed Round | 0 |
5/2021 | Hangzhou DAC Biotech Co., Ltd | Series C | 0 |
3/2021 | Novamab | Series A | 0 |
1/2021 | MagAssist | Series B | 0 |
12/2020 | Insight Lifetech | Series C | 0 |
4/2020 | Precogify | Seed Round | 0 |
4/2018 | Hanyu Medical | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|